Los Angeles Capital Management LLC cut its position in Agilon Health, Inc. (NYSE:AGL – Free Report) by 87.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 16,223 shares of the company’s stock after selling 114,256 shares during the period. Los Angeles Capital Management LLC’s holdings in Agilon Health were worth $37,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in AGL. Bank of New York Mellon Corp increased its position in shares of Agilon Health by 4.3% during the first quarter. Bank of New York Mellon Corp now owns 807,761 shares of the company’s stock valued at $3,498,000 after acquiring an additional 32,959 shares in the last quarter. Cerity Partners LLC boosted its stake in Agilon Health by 137.6% during the 1st quarter. Cerity Partners LLC now owns 43,133 shares of the company’s stock valued at $187,000 after purchasing an additional 24,977 shares during the last quarter. CWM LLC increased its holdings in shares of Agilon Health by 199.0% in the 1st quarter. CWM LLC now owns 36,514 shares of the company’s stock worth $158,000 after purchasing an additional 24,300 shares in the last quarter. Signaturefd LLC raised its stake in shares of Agilon Health by 28.3% in the first quarter. Signaturefd LLC now owns 18,461 shares of the company’s stock worth $80,000 after purchasing an additional 4,073 shares during the last quarter. Finally, Private Advisor Group LLC lifted its holdings in shares of Agilon Health by 49.9% during the first quarter. Private Advisor Group LLC now owns 53,254 shares of the company’s stock valued at $231,000 after purchasing an additional 17,731 shares in the last quarter.
Agilon Health Trading Up 1.1%
Shares of NYSE AGL opened at $0.54 on Wednesday. Agilon Health, Inc. has a 12-month low of $0.53 and a 12-month high of $6.08. The firm has a market capitalization of $225.12 million, a price-to-earnings ratio of -0.72 and a beta of 0.05. The firm has a 50 day moving average of $0.94 and a 200 day moving average of $1.63.
Analyst Ratings Changes
Several equities research analysts recently commented on the company. Jefferies Financial Group reduced their price objective on Agilon Health from $2.40 to $1.10 and set a “hold” rating for the company in a report on Friday, August 15th. Wells Fargo & Company reduced their price target on shares of Agilon Health from $1.50 to $1.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Zacks Research upgraded shares of Agilon Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, October 21st. Robert W. Baird dropped their target price on shares of Agilon Health from $5.00 to $1.00 and set a “neutral” rating on the stock in a report on Thursday, August 14th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research note on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Agilon Health has an average rating of “Hold” and a consensus target price of $2.73.
Read Our Latest Analysis on Agilon Health
Agilon Health Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
- Five stocks we like better than Agilon Health
- What Do S&P 500 Stocks Tell Investors About the Market?
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- Differences Between Momentum Investing and Long Term Investing
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- Why is the Ex-Dividend Date Significant to Investors?
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilon Health, Inc. (NYSE:AGL – Free Report).
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
